nach oben

The International Journal of Cardiovascular Imaging

Erschienen in:

01.02.2016 | Original Paper

Relationship between epicardial fat and quantitative coronary artery plaque progression: insights from computer tomography coronary angiography

verfasst von: Peter J. Psaltis, Andrew H. Talman, Kiran Munnur, James D. Cameron, Brian S. H. Ko, Ian T. Meredith, Sujith K. Seneviratne, Dennis T. L. Wong

Erschienen in: The International Journal of Cardiovascular Imaging | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Epicardial fat volume (EFV) has been suggested to promote atherosclerotic plaque development in coronary arteries, and has been correlated with both coronary stenosis and acute coronary events. Although associated with progression of coronary calcification burden, a relationship with progression of coronary atheroma volume has not been previously tested. We studied patients who had clinically indicated serial 320-row multi-detector computer tomography coronary angiography with a median 25-month interval. EFV was measured at baseline and follow-up. In vessels with coronary stenosis, quantitative analysis was performed to measure atherosclerotic plaque burden, volume and aggregate plaque volume at baseline and follow-up. The study comprised 64 patients (58.4 ± 12.2 years, 27 males, 192 vessels, 193 coronary segments). 79 (41 %) coronary segments had stenosis at baseline. Stenotic segments were associated with greater baseline EFV than those without coronary stenosis (117.4 ± 45.1 vs. 102.3 ± 51.6 cm³, P = 0.046). 46 (24 %) coronary segments displayed either new plaque formation or progression of adjusted plaque burden at follow-up. These were associated with higher baseline EFV than segments without stenosis or those segments that had stenoses that did not progress (128.7 vs. 101.0 vs. 106.7 cm³ respectively, P = 0.006). On multivariate analysis, baseline EFV was the only independent predictor of coronary atherosclerotic plaque progression or new development (P = 0.014). High baseline EFV is associated with the presence of coronary artery stenosis and plaque volume progression. Accumulation of EFV may be implicated in the evolution and progression of coronary atheroma.

Sacks HS, Fain JN (2007) Human epicardial adipose tissue: a review. Am Heart J 153(6):907–917. doi:10.1016/j.ahj.2007.03.019 CrossRefPubMed

Marchington JM, Mattacks CA, Pond CM (1989) Adipose tissue in the mammalian heart and pericardium: structure, foetal development and biochemical properties. Comp Biochem Physiol B Comp Biochem 94(2):225–232CrossRef

Larsson B, Svardsudd K, Welin L, Wilhelmsen L, Bjorntorp P, Tibblin G (1984) Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br Med J (Clin Res Ed) 288(6428):1401–1404CrossRef

Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, Arafat H, Sarov-Blat L, O’Brien S, Keiper EA, Johnson AG, Martin J, Goldstein BJ, Shi Y (2003) Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 108(20):2460–2466. doi:10.1161/01.CIR.0000099542.57313.C5 CrossRefPubMed

Baker AR, Silva NF, Quinn DW, Harte AL, Pagano D, Bonser RS, Kumar S, McTernan PG (2006) Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol 5:1. doi:10.1186/1475-2840-5-1 PubMedCentralCrossRefPubMed

Libby P, Ridker PM, Maseri A (2002) Inflammation and atherosclerosis. Circulation 105(9):1135–1143CrossRefPubMed

Rosito GA, Massaro JM, Hoffmann U, Ruberg FL, Mahabadi AA, Vasan RS, O’Donnell CJ, Fox CS (2008) Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation 117(5):605–613. doi:10.1161/CIRCULATIONAHA.107.743062 CrossRefPubMed

Ding J, Kritchevsky SB, Harris TB, Burke GL, Detrano RC, Szklo M, Jeffrey Carr J (2008) The association of pericardial fat with calcified coronary plaque. Obesity 16(8):1914–1919. doi:10.1038/oby.2008.278 PubMedCentralCrossRefPubMed

Ahmadi N, Nabavi V, Yang E, Hajsadeghi F, Lakis M, Flores F, Zeb I, Bevinal M, Ebrahimi R, Budoff M (2010) Increased epicardial, pericardial, and subcutaneous adipose tissue is associated with the presence and severity of coronary artery calcium. Acad Radiol 17(12):1518–1524. doi:10.1016/j.acra.2010.08.017 CrossRefPubMed

10.

Iwasaki K, Matsumoto T, Aono H, Furukawa H, Samukawa M (2011) Relationship between epicardial fat measured by 64-multidetector computed tomography and coronary artery disease. Clin Cardiol 34(3):166–171. doi:10.1002/clc.20840 CrossRefPubMed

11.

Alexopoulos N, McLean DS, Janik M, Arepalli CD, Stillman AE, Raggi P (2010) Epicardial adipose tissue and coronary artery plaque characteristics. Atherosclerosis 210(1):150–154. doi:10.1016/j.atherosclerosis.2009.11.020 CrossRefPubMed

12.

Schlett CL, Ferencik M, Kriegel MF, Bamberg F, Ghoshhajra BB, Joshi SB, Nagurney JT, Fox CS, Truong QA, Hoffmann U (2012) Association of pericardial fat and coronary high-risk lesions as determined by cardiac CT. Atherosclerosis 222(1):129–134. doi:10.1016/j.atherosclerosis.2012.02.029 PubMedCentralCrossRefPubMed

13.

Rajani R, Shmilovich H, Nakazato R, Nakanishi R, Otaki Y, Cheng VY, Hayes SW, Thomson LE, Friedman JD, Slomka PJ, Min JK, Berman DS, Dey D (2013) Relationship of epicardial fat volume to coronary plaque, severe coronary stenosis, and high-risk coronary plaque features assessed by coronary CT angiography. J Cardiovasc Comput Tomogr 7(2):125–132. doi:10.1016/j.jcct.2013.02.003 PubMedCentralCrossRefPubMed

14.

Mahabadi AA, Berg MH, Lehmann N, Kalsch H, Bauer M, Kara K, Dragano N, Moebus S, Jockel KH, Erbel R, Mohlenkamp S (2013) Association of epicardial fat with cardiovascular risk factors and incident myocardial infarction in the general population: the Heinz Nixdorf Recall Study. J Am Coll Cardiol 61(13):1388–1395. doi:10.1016/j.jacc.2012.11.062 CrossRefPubMed

15.

Ding J, Hsu FC, Harris TB, Liu Y, Kritchevsky SB, Szklo M, Ouyang P, Espeland MA, Lohman KK, Criqui MH, Allison M, Bluemke DA, Carr JJ (2009) The association of pericardial fat with incident coronary heart disease: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr 90(3):499–504. doi:10.3945/ajcn.2008.27358 PubMedCentralCrossRefPubMed

16.

Davidovich D, Gastaldelli A, Sicari R (2013) Imaging cardiac fat. Eur Heart J Cardiovasc Imaging 14(7):625–630. doi:10.1093/ehjci/jet045 CrossRefPubMed

17.

Yerramasu A, Dey D, Venuraju S, Anand DV, Atwal S, Corder R, Berman DS, Lahiri A (2012) Increased volume of epicardial fat is an independent risk factor for accelerated progression of sub-clinical coronary atherosclerosis. Atherosclerosis 220(1):223–230. doi:10.1016/j.atherosclerosis.2011.09.041 CrossRefPubMed

18.

Konishi M, Sugiyama S, Sugamura K, Nozaki T, Ohba K, Matsubara J, Matsuzawa Y, Sumida H, Nagayoshi Y, Nakaura T, Awai K, Yamashita Y, Jinnouchi H, Matsui K, Kimura K, Umemura S, Ogawa H (2010) Association of pericardial fat accumulation rather than abdominal obesity with coronary atherosclerotic plaque formation in patients with suspected coronary artery disease. Atherosclerosis 209(2):573–578. doi:10.1016/j.atherosclerosis.2009.10.008 CrossRefPubMed

19.

Lehman SJ, Schlett CL, Bamberg F, Lee H, Donnelly P, Shturman L, Kriegel MF, Brady TJ, Hoffmann U (2009) Assessment of coronary plaque progression in coronary computed tomography angiography using a semiquantitative score. JACC Cardiovasc Imaging 2(11):1262–1270. doi:10.1016/j.jcmg.2009.07.007 PubMedCentralCrossRefPubMed

20.

Wong DT, Soh SY, Ko BS, Cameron JD, Crossett M, Nasis A, Troupis J, Meredith IT, Seneviratne SK (2014) Superior CT coronary angiography image quality at lower radiation exposure with second generation 320-detector row CT in patients with elevated heart rate: a comparison with first generation 320-detector row CT. Cardiovasc Diagn Ther 4(4):299–306. doi:10.3978/j.issn.2223-3652.2014.08.05 PubMedCentralPubMed

21.

Owen MK, Noblet JN, Sassoon DJ, Conteh AM, Goodwill AG, Tune JD (2014) Perivascular adipose tissue and coronary vascular disease. Arterioscler Thromb Vasc Biol 34(8):1643–1649. doi:10.1161/ATVBAHA.114.303033 PubMedCentralCrossRefPubMed

22.

Talman AH, Psaltis PJ, Cameron JD, Meredith IT, Seneviratne SK, Wong DT (2014) Epicardial adipose tissue: far more than a fat depot. Cardiovasc Diagn Ther 4(6):416–429. doi:10.3978/j.issn.2223-3652.2014.11.05 PubMedCentralPubMed

23.

Nakanishi K, Fukuda S, Tanaka A, Otsuka K, Jissho S, Taguchi H, Yoshikawa J, Shimada K (2014) Persistent epicardial adipose tissue accumulation is associated with coronary plaque vulnerability and future acute coronary syndrome in non-obese subjects with coronary artery disease. Atherosclerosis 237(1):353–360. doi:10.1016/j.atherosclerosis.2014.09.015 CrossRefPubMed

24.

Oikawa M, Owada T, Yamauchi H, Misaka T, Machii H, Yamaki T, Sugimoto K, Kunii H, Nakazato K, Suzuki H, Saitoh S, Takeishi Y (2015) Epicardial adipose tissue reflects the presence of coronary artery disease: comparison with abdominal visceral adipose tissue. BioMed Res Int 2015:483982. doi:10.1155/2015/483982 PubMedCentralCrossRefPubMed

25.

Iacobellis G, Singh N, Wharton S, Sharma AM (2008) Substantial changes in epicardial fat thickness after weight loss in severely obese subjects. Obesity 16(7):1693–1697. doi:10.1038/oby.2008.251 CrossRefPubMed

26.

Nelson AJ, Worthley MI, Psaltis PJ, Carbone A, Dundon BK, Duncan RF, Piantadosi C, Lau DH, Sanders P, Wittert GA, Worthley SG (2009) Validation of cardiovascular magnetic resonance assessment of pericardial adipose tissue volume. J Cardiovasc Magn Reson 11:15. doi:10.1186/1532-429X-11-15 PubMedCentralCrossRefPubMed

27.

Bastarrika G, Broncano J, Schoepf UJ, Schwarz F, Lee YS, Abro JA, Costello P, Zwerner PL (2010) Relationship between coronary artery disease and epicardial adipose tissue quantification at cardiac CT: comparison between automatic volumetric measurement and manual bidimensional estimation. Acad Radiol 17(6):727–734. doi:10.1016/j.acra.2010.01.015 CrossRefPubMed

28.

Nakazato R, Shmilovich H, Tamarappoo BK, Cheng VY, Slomka PJ, Berman DS, Dey D (2011) Interscan reproducibility of computer-aided epicardial and thoracic fat measurement from noncontrast cardiac CT. J Cardiovasc Comput Tomogr 5(3):172–179. doi:10.1016/j.jcct.2011.03.009 PubMedCentralCrossRefPubMed

29.

Nichols JH, Samy B, Nasir K, Fox CS, Schulze PC, Bamberg F, Hoffmann U (2008) Volumetric measurement of pericardial adipose tissue from contrast-enhanced coronary computed tomography angiography: a reproducibility study. J Cardiovasc Comput Tomogr 2(5):288–295. doi:10.1016/j.jcct.2008.08.008 PubMedCentralCrossRefPubMed

30.

Zeb I, Li D, Nasir K, Malpeso J, Batool A, Flores F, Dailing C, Karlsberg RP, Budoff M (2013) Effect of statin treatment on coronary plaque progression—a serial coronary CT angiography study. Atherosclerosis 231(2):198–204. doi:10.1016/j.atherosclerosis.2013.08.019 CrossRefPubMed

31.

Callister TQ, Raggi P, Cooil B, Lippolis NJ, Russo DJ (1998) Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography. N Engl J Med 339(27):1972–1978. doi:10.1056/NEJM199812313392703 CrossRefPubMed

32.

Inoue K, Motoyama S, Sarai M, Sato T, Harigaya H, Hara T, Sanda Y, Anno H, Kondo T, Wong ND, Narula J, Ozaki Y (2010) Serial coronary CT angiography-verified changes in plaque characteristics as an end point: evaluation of effect of statin intervention. JACC Cardiovasc Imaging 3(7):691–698. doi:10.1016/j.jcmg.2010.04.011 CrossRefPubMed

33.

Maurovich-Horvat P, Ferencik M, Bamberg F, Hoffmann U (2009) Methods of plaque quantification and characterization by cardiac computed tomography. J Cardiovasc Comput Tomogr 3(Suppl 2):S91–S98. doi:10.1016/j.jcct.2009.10.012 CrossRefPubMed

34.

Voros S, Rinehart S, Qian Z, Joshi P, Vazquez G, Fischer C, Belur P, Hulten E, Villines TC (2011) Coronary atherosclerosis imaging by coronary CT angiography: current status, correlation with intravascular interrogation and meta-analysis. JACC Cardiovasc Imaging 4(5):537–548. doi:10.1016/j.jcmg.2011.03.006 CrossRefPubMed

35.

Leber AW, Becker A, Knez A, von Ziegler F, Sirol M, Nikolaou K, Ohnesorge B, Fayad ZA, Becker CR, Reiser M, Steinbeck G, Boekstegers P (2006) Accuracy of 64-slice computed tomography to classify and quantify plaque volumes in the proximal coronary system: a comparative study using intravascular ultrasound. J Am Coll Cardiol 47(3):672–677. doi:10.1016/j.jacc.2005.10.058 CrossRefPubMed

36.

Schmid M, Achenbach S, Ropers D, Komatsu S, Ropers U, Daniel WG, Pflederer T (2008) Assessment of changes in non-calcified atherosclerotic plaque volume in the left main and left anterior descending coronary arteries over time by 64-slice computed tomography. Am J Cardiol 101(5):579–584. doi:10.1016/j.amjcard.2007.10.016 CrossRefPubMed

37.

Burgstahler C, Reimann A, Beck T, Kuettner A, Baumann D, Heuschmid M, Brodoefel H, Claussen CD, Kopp AF, Schroeder S (2007) Influence of a lipid-lowering therapy on calcified and noncalcified coronary plaques monitored by multislice detector computed tomography: results of the New Age II Pilot Study. Invest Radiol 42(3):189–195. doi:10.1097/01.rli.0000254408.96355.85 CrossRefPubMed

38.

Ito H, Motoyama S, Sarai M, Kawai H, Harigaya H, Kan S, Kato S, Anno H, Takahashi H, Naruse H, Ishii J, Narula J, Ozaki Y (2014) Characteristics of plaque progression detected by serial coronary computed tomography angiography. Heart Vessels 29(6):743–749. doi:10.1007/s00380-013-0420-4 CrossRefPubMed

39.

Voros S, Rinehart S, Qian Z, Vazquez G, Anderson H, Murrieta L, Wilmer C, Carlson H, Taylor K, Ballard W, Karmpaliotis D, Kalynych A, Brown C 3rd (2011) Prospective validation of standardized, 3-dimensional, quantitative coronary computed tomographic plaque measurements using radiofrequency backscatter intravascular ultrasound as reference standard in intermediate coronary arterial lesions: results from the ATLANTA (assessment of tissue characteristics, lesion morphology, and hemodynamics by angiography with fractional flow reserve, intravascular ultrasound and virtual histology, and noninvasive computed tomography in atherosclerotic plaques) I study. JACC Cardiovasc Interv 4(2):198–208. doi:10.1016/j.jcin.2010.10.008 CrossRefPubMed

40.

Wang JC, Normand SL, Mauri L, Kuntz RE (2004) Coronary artery spatial distribution of acute myocardial infarction occlusions. Circulation 110(3):278–284. doi:10.1161/01.CIR.0000135468.67850.F4 CrossRefPubMed

41.

Okura K, Maeno K, Okura S, Takemori H, Toya D, Tanaka N, Miyayama S (2015) Pericardial fat volume is an independent risk factor for the severity of coronary artery disease in patients with preserved ejection fraction. J Cardiol 65(1):37–41. doi:10.1016/j.jjcc.2014.03.015 CrossRefPubMed

42.

Greif M, Becker A, von Ziegler F, Lebherz C, Lehrke M, Broedl UC, Tittus J, Parhofer K, Becker C, Reiser M, Knez A, Leber AW (2009) Pericardial adipose tissue determined by dual source CT is a risk factor for coronary atherosclerosis. Arterioscler Thromb Vasc Biol 29(5):781–786. doi:10.1161/ATVBAHA.108.180653 CrossRefPubMed

43.

Ito T, Suzuki Y, Ehara M, Matsuo H, Teramoto T, Terashima M, Nasu K, Kinoshita Y, Tsuchikane E, Suzuki T, Kimura G (2013) Impact of epicardial fat volume on coronary artery disease in symptomatic patients with a zero calcium score. Int J Cardiol 167(6):2852–2858. doi:10.1016/j.ijcard.2012.07.026 CrossRefPubMed

44.

Park JH, Park YS, Kim YJ, Lee IS, Kim JH, Lee JH, Choi SW, Jeong JO, Seong IW (2010) Effects of statins on the epicardial fat thickness in patients with coronary artery stenosis underwent percutaneous coronary intervention: comparison of atorvastatin with simvastatin/ezetimibe. J Cardiovasc Ultrasound 18(4):121–126. doi:10.4250/jcu.2010.18.4.121 PubMedCentralCrossRefPubMed

45.

Gaborit B, Jacquier A, Kober F, Abdesselam I, Cuisset T, Boullu-Ciocca S, Emungania O, Alessi MC, Clement K, Bernard M, Dutour A (2012) Effects of bariatric surgery on cardiac ectopic fat: lesser decrease in epicardial fat compared to visceral fat loss and no change in myocardial triglyceride content. J Am Coll Cardiol 60(15):1381–1389. doi:10.1016/j.jacc.2012.06.016 CrossRefPubMed

Titel: Relationship between epicardial fat and quantitative coronary artery plaque progression: insights from computer tomography coronary angiography
verfasst von: Peter J. Psaltis
Andrew H. Talman
Kiran Munnur
James D. Cameron
Brian S. H. Ko
Ian T. Meredith
Sujith K. Seneviratne
Dennis T. L. Wong
Publikationsdatum: 01.02.2016
Verlag: Springer Netherlands
Erschienen in: The International Journal of Cardiovascular Imaging / Ausgabe 2/2016
Print ISSN: 1569-5794
Elektronische ISSN: 1875-8312
DOI: https://doi.org/10.1007/s10554-015-0762-3

Neu im Fachgebiet Kardiologie

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Relationship between epicardial fat and quantitative coronary artery plaque progression: insights from computer tomography coronary angiography

Abstract

Neu im Fachgebiet Kardiologie

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

Update Kardiologie

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2016

Distinction of non-ischemia inducing versus ischemia inducing coronary stenosis by fluorescent cardiac imaging

Dose correction for post-contrast T1 mapping of the heart: the MESA study

Reviewer Acknowledgments

A low-dose, dual-phase cardiovascular CT protocol to assess left atrial appendage anatomy and exclude thrombus prior to left atrial intervention

Multi-institutional evaluation of the indications and radiation dose of functional cardiovascular computed tomography (CCT) imaging in congenital heart disease

Qualitative grading of aortic regurgitation: a pilot study comparing CMR 4D flow and echocardiography

Neu im Fachgebiet Kardiologie

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

Update Kardiologie